JP2012533322A5 - - Google Patents

Download PDF

Info

Publication number
JP2012533322A5
JP2012533322A5 JP2012521710A JP2012521710A JP2012533322A5 JP 2012533322 A5 JP2012533322 A5 JP 2012533322A5 JP 2012521710 A JP2012521710 A JP 2012521710A JP 2012521710 A JP2012521710 A JP 2012521710A JP 2012533322 A5 JP2012533322 A5 JP 2012533322A5
Authority
JP
Japan
Prior art keywords
expression
ibd
expression level
determining
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012521710A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012533322A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/042487 external-priority patent/WO2011011339A1/en
Publication of JP2012533322A publication Critical patent/JP2012533322A/ja
Publication of JP2012533322A5 publication Critical patent/JP2012533322A5/ja
Pending legal-status Critical Current

Links

JP2012521710A 2009-07-20 2010-07-19 クローン病のための遺伝子発現マーカー Pending JP2012533322A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22704909P 2009-07-20 2009-07-20
US61/227,049 2009-07-20
US30208410P 2010-02-05 2010-02-05
US61/302,084 2010-02-05
PCT/US2010/042487 WO2011011339A1 (en) 2009-07-20 2010-07-19 Gene expression markers for crohn's disease

Publications (2)

Publication Number Publication Date
JP2012533322A JP2012533322A (ja) 2012-12-27
JP2012533322A5 true JP2012533322A5 (enExample) 2013-09-05

Family

ID=42732741

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012521710A Pending JP2012533322A (ja) 2009-07-20 2010-07-19 クローン病のための遺伝子発現マーカー

Country Status (8)

Country Link
US (2) US20110033486A1 (enExample)
EP (3) EP2456890A1 (enExample)
JP (1) JP2012533322A (enExample)
CN (1) CN102639710A (enExample)
AU (1) AU2010276392A1 (enExample)
CA (1) CA2768711A1 (enExample)
SG (1) SG177699A1 (enExample)
WO (1) WO2011011339A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
WO2015168699A1 (en) * 2014-05-02 2015-11-05 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (mruc) requiring colectomy
WO2010075579A2 (en) 2008-12-24 2010-07-01 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (mr-uc) requiring colectomy
ES2650228T3 (es) 2011-03-25 2018-01-17 Cedars-Sinai Medical Center Métodos de diagnóstico de colitis ulcerosa y enfermedad de Crohn
JP6923291B2 (ja) * 2012-07-12 2021-08-18 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 少なくとも７個の遺伝子のサインを用いて、固形癌を患う患者の生存期間および処置に対する応答性を予測するための方法
KR20240122922A (ko) 2013-03-27 2024-08-13 세다르스-신나이 메디칼 센터 Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한 섬유증 및 염증의 완화 및 반전
MX2015015784A (es) * 2013-05-17 2016-03-11 Genentech Inc Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino.
EP3022295A4 (en) 2013-07-19 2017-03-01 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
JP7054990B2 (ja) 2014-03-27 2022-04-15 ジェネンテック， インコーポレイテッド 炎症性腸疾患の診断及び治療のための方法
CN109462996A (zh) 2016-03-17 2019-03-12 西达-赛奈医疗中心 通过rnaset2诊断炎性肠病的方法
CN107541790B (zh) * 2016-06-24 2021-07-06 上海交通大学 一种糖基化检测的人凝集素/类人凝集素芯片及制备方法
IT201600090052A1 (it) * 2016-09-06 2018-03-06 Univ Degli Studi Padova Peptide per la diagnosi differenziale della Malattia di Crohn
CN106755293B (zh) * 2016-09-23 2020-09-04 宁波大学 一种与肺癌辅助诊断相关的lncRNA标志物及其应用
US10890579B2 (en) 2016-10-06 2021-01-12 The Research Foundation For The State University Of New York Methods and kits for detecting a fusion messenger RNA transcript or a polypeptide encoded by the fusion messenger RNA transcript
CN112041933B (zh) * 2018-03-14 2025-05-13 皇家飞利浦有限公司 使用局部独特特征来解释rna测序数据的转录本表达水平的系统和方法
CN108893488A (zh) * 2018-06-19 2018-11-27 刘志强 一种重组质粒、dna疫苗及其制备方法和应用
EP3969621A4 (en) 2019-05-14 2023-01-25 Prometheus Biosciences, Inc. TL1A PATIENT SELECTION METHODS, SYSTEMS AND DEVICES
CN112578122B (zh) * 2019-09-27 2022-08-02 成都中医药大学 检测粪钙卫蛋白含量的试剂在制备畸形精子症筛查试剂盒中的用途
CN116168765B (zh) * 2023-04-25 2023-08-18 山东大学 基于改进strobemer的基因序列生成方法及系统
CN117031004B (zh) * 2023-08-09 2024-10-01 四川省医学科学院·四川省人民医院 一种检测网膜素-1的试剂在制备预测或评估ibs患者生活质量的产品中的应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
EP0739904A1 (en) 1989-06-29 1996-10-30 Medarex, Inc. Bispecific reagents for aids therapy
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
EP0527283B1 (en) 1991-08-12 1997-11-26 Societe Des Produits Nestle S.A. Food composition
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
FI941572L (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
DE69233528T2 (de) 1991-11-25 2006-03-16 Enzon, Inc. Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen
CA2372813A1 (en) 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker
EP0626012B1 (en) 1992-02-11 2003-07-09 Cell Genesys, Inc. Homogenotization of gene-targeting events
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
DE69308573T2 (de) 1992-08-17 1997-08-07 Genentech Inc Bispezifische immunoadhesine
US6283761B1 (en) 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
CA2223198A1 (en) 1997-01-14 1998-07-14 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
PT2857516T (pt) 2000-04-11 2017-08-28 Genentech Inc Anticorpos multivalentes e utilizações dos mesmos
GB0130955D0 (en) 2001-12-24 2002-02-13 Cancer Res Ventures Expression system
US20030166282A1 (en) 2002-02-01 2003-09-04 David Brown High potency siRNAS for reducing the expression of target genes
US7378239B2 (en) * 2002-06-25 2008-05-27 Index Diagnostics Ab Method of differentiating between ulcerative colitis and Crohn's disease
ES2905579T3 (es) 2003-07-10 2022-04-11 Genomic Health Inc Algoritmo del perfil de expresión y prueba para el pronóstico de la recaída del cáncer de mama
JP2005102694A (ja) * 2003-09-10 2005-04-21 Japan Science & Technology Agency 末梢血液細胞に示差的に発現されている遺伝子群、およびそれを用いた診断方法とアッセイ方法
WO2006063133A2 (en) * 2004-12-06 2006-06-15 The Johns Hopkins University Biomarker for inflammatory bowel disease
EP2049691A4 (en) * 2006-07-26 2010-06-16 Genizon Biosciences Inc SUSCEPTIBILITY TREASURES FOR MORBUS CROHN
WO2008079406A2 (en) * 2006-12-19 2008-07-03 Genentech, Inc. Gene expression markers for inflammatory bowel disease
WO2008147900A2 (en) * 2007-05-22 2008-12-04 Genentech, Inc. Gene expression markers for inflammatory bowel disease
WO2008147869A2 (en) * 2007-05-22 2008-12-04 Centocor, Inc. Markers and methods for assessing and treating crohn's disease and related disorders
AU2008334095A1 (en) * 2007-11-29 2009-06-11 Genentech, Inc. Gene expression markers for inflammatory bowel disease
CA2747253A1 (en) * 2007-12-20 2009-07-02 Index Diagnostics Ab Method and kit for use in the differentiation of ibd and ibs and further distinction between disease types of ibd

Similar Documents

Publication Publication Date Title
JP2011509071A5 (enExample)
CN105473739B (zh) 结直肠癌生物标志物
Cao et al. Role of MiRNAs in inflammatory bowel disease
Quereda et al. The Listeria small RNA Rli27 regulates a cell wall protein inside eukaryotic cells by targeting a long 5′-UTR variant
JP2016507233A5 (enExample)
WO2012080754A3 (en) Oligonucleotide probe set and methods of microbiota profiling
JP2024023373A (ja) 大腸がんの検出キット又はデバイス及び検出方法
JP2012518421A5 (enExample)
KR20170015509A (ko) 담도암 검출 키트 또는 디바이스 및 검출 방법
Pang et al. miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma
JP2011511804A5 (enExample)
JP2012500389A5 (enExample)
JP2012503985A5 (enExample)
JP2014509189A5 (enExample)
WO2014186750A2 (en) Variants of tnfsf15 and dcr3 associated with crohn's disease
WO2009116861A3 (en) Diagnostic of pre-symptomatic metabolic syndrome
JP2010527917A5 (enExample)
JP2013178260A5 (enExample)
US20160096885A1 (en) Distinct effects of ifn-gamma and il-17 on tl1a modulated inflammation and fibrosis
WO2012032519A3 (en) Methods of diagnosing parkinson's disease
JPWO2019208671A5 (enExample)
Murdaca et al. The role of skin and gut microbiome and epigenetic modifications in skin-autoimmune disorders
WO2009125303A3 (en) Method and apparatus for determining a probability of colorectal cancer in a subject
JP2011527575A5 (enExample)
Meniaï et al. Putative antigenic proteins identified by comparative and subtractive reverse vaccinology in necrotic enteritis-causing Clostridium perfringens isolated from broiler chickens